Use of Doxycycline in a Renal Impaired Patient with Enterococcal Sepsis
International Journal of Medical and Pharmaceutical Case Reports,
Aim: This report highlights the use of doxycycline therapy other than the more standard regimen that includes an aminoglycoside in the management of enterococcal infection in patients with renal impairment without causing further damages to the kidney due to aminoglycoside therapy.
Presentation of Case: A case of enterococcal septicemia in a 29-year-old woman who was admitted on account of acute kidney injury secondary to pregnancy induced hypertension in the setting of pre-eclampsia. She was referred from another centre where she had emergency caesarean section done on account of severe pre-eclampsia at 36 weeks gestational age. Blood culture yielded Enterococcus species. When other antibiotic regimen failed, she was started on doxycycline. Patient had good clinical response and was discharged 7 days after commencement of doxycycline.
Discussion: Enterococci have emerged as important agent of human disease largely because of their resistance to antimicrobial agents. They are important nosocomial pathogens capable of causing serious and potentially life-threatening infections, including sepsis. The incidence of enterococcal infections, mainly hospital-acquired, has increased over the past 2 decades and isolates with novel mechanism of resistance to antimicrobial agents are more and more frequent. Furthermore, they have great capacity for transmitting these resistances to other species and even to other genera.
Conclusion: Doxycycline is a safe and effective alternative antibiotic for the treatment of enterococcal sepsis in patients with impaired renal status.
- enterococcal infections
- renal impairment
How to Cite
Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL. A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clinical Infectious Diseases. 2018;67(2): 303–309.
David L, John MQ. Management of infections due to resistant enteroccoci: A review of therapeutic options. Journal of Antimicrobial Chemotherapy. 1997;40:161-170.
Launay-Vacher V, Izzedine H, Mercadal L and Deray G. Clinical review: Use of vancomycin in haemodialysis patients. Critical Care. 2002;6:313-316.
Selby NM, Shaw S, Woodier N, Fluck RJ, Kolhe NV. Gentamicin-associated acute kidney injury. QJM: An International Journal of Medicine. 2009;102:873–880.
Landry SL, Kaiser DL, Wenzel RP. Hospital stay and Mortality attributed to Nosocomial Enterococcal Bacteriamia: A controlled study. American Journal of Infection Control. 1989;17(6):323-329.
Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clinical Microbiology Reviews. 1993;6(4):428-42.
Houin G, Brunner F, Nebout Th, Cherfaoui M, Lagrue G, Tillement JP. The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man. British Journal of Clinical Pharmacy. 1983; 16:245–252.
Mahon WA, Wittenberg JVP, Tuffnel PG. Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function. C.M.A. Journal. 1970;103.
Abstract View: 71 times
PDF Download: 37 times